Skandinaviska Enskilda Banken (SEB)’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-96,353
Closed -$16.8M 431
2025
Q4
$16.8M Buy
96,353
+41,569
+76% +$7.59M 0.07% 206
2025
Q3
$7.89M Buy
54,784
+26,995
+97% +$3.31M 0.03% 327
2025
Q2
$2.8M Hold
27,789
0.01% 524
2025
Q1
$2.12M Buy
27,789
+6,705
+32% +$513K 0.01% 560
2024
Q4
$1.45M Hold
21,084
0.01% 618
2024
Q3
$1.54M Buy
21,084
+3,192
+18% +$236K 0.01% 628
2024
Q2
$1.2M Buy
+17,892
New +$694K 0.01% 625
2020
Q3
Sell
-10,700
Closed -$295K 1076
2020
Q2
$295K Buy
+10,700
New +$254K ﹤0.01% 876

Other funds holding INSM

Skandinaviska Enskilda Banken (SEB)'s INSM Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Insmed (INSM) in Q1 2026, closing a stake of 96,353 shares — an estimated $16.8M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in INSM in Q2 2020 and held it in 8 quarters. The position peaked at $16.8M in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 96,353 Insmed shares in Q1 2026, an estimated $16.8M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Insmed in Q2 2020 and held it in 8 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Insmed position peaked at $16.8M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.